Ico Institut Catala D Oncologia

L'Hospitalet de Llobregat 08908

0 studies enrolling now · 4 studies all time

What they study most

Adult-type Diffuse Gliomas, Advanced Malignancies, Chronic Graft-versus-host Disease, Glioblastoma, Non-Small Cell Lung Cancer (NSCLC)

Studies at this site

• Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Glioblastoma or Other Primary Central Nervous System Tumors Harboring Activating FGFR1-3 Alterations — Stopped early
• Study of INCA32459 a LAG-3 and PD-1 Bispecific Antibody in Participants With Select Advanced Malignancies — Completed
• GRAVITAS-309: Itacitinib and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease — Stopped early
• Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Relapsed or Refractory Advanced Non-Small Cell Lung Cancer With an FGFR Alteration — Completed